Literature DB >> 30297331

Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism.

Kulveer Mankia1,2, Maria-Antonietta D'Agostino1,3,4, Richard J Wakefield1,2, Jackie L Nam1,2, Waqar Mahmood1, Andrew J Grainger2,5, Paul Emery6,2.   

Abstract

OBJECTIVES: To use high-resolution imaging to characterise palindromic rheumatism (PR) and to compare the imaging pattern observed to that seen in new-onset rheumatoid arthritis (NORA).
METHODS: Ultrasound (US) assessment of synovitis, tenosynovitis and non-synovial extracapsular inflammation (ECI) was performed during and between flares in a prospective treatment-naive PR cohort. MRI of the flaring region was performed where possible. For comparison, the same US assessment was also performed in anticyclic citrullinated peptide (CCP) positive individuals with musculoskeletal symptoms (CCP+ at risk) and patients with NORA.
RESULTS: Thirty-one of 79 patients with PR recruited were assessed during a flare. A high frequency of ECI was identified on US; 19/31 (61%) of patients had ECI including 12/19 (63%) in whom ECI was identified in the absence of synovitis. Only 7/31 (23%) patients with PR had synovitis (greyscale ≥1 and power Doppler ≥1) during flare. In the hands/wrists, ECI was more prevalent in PR compared with NORA and CCP+ at risk (65% vs 29 % vs 6%, p<0.05). Furthermore, ECI without synovitis was specific for PR (42% PR vs 4% NORA (p=0.003) and 6% CCP+ at risk (p=0.0012)). Eleven PR flares were captured by MRI, which was more sensitive than US for synovitis and ECI. 8/31 (26%) patients with PR developed RA and had a similar US phenotype to NORA at progression.
CONCLUSION: PR has a distinct US pattern characterised by reversible ECI, often without synovitis. In patients presenting with new joint swelling, US may refine management by distinguishing relapsing from persistent arthritis. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  anti-CCP; early rheumatoid arthritis; magnetic resonance imaging; ultrasonography

Mesh:

Substances:

Year:  2018        PMID: 30297331     DOI: 10.1136/annrheumdis-2018-214175

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

Review 1.  The value of MRI for detecting subclinical joint inflammation in clinically suspect arthralgia.

Authors:  Anna M P Boeren; Edwin H G Oei; Annette H M van der Helm-van Mil
Journal:  RMD Open       Date:  2022-07

2.  Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis.

Authors:  Raul Castellanos-Moreira; Sebastian C Rodriguez-Garcia; Sonia Cabrera-Villalba; María José Gomara; Georgina Salvador; Virginia Ruiz-Esquide; Julio Ramirez; Jose Inciarte-Mundo; Rosa Morla; Cristina Garcia-Moreno; Andrea Cuervo; Jose A Gómez-Puerta; Juan D Cañete; Isabel Haro; Raimon Sanmarti
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-10       Impact factor: 5.346

3.  Palindromic Rheumatism: Just a Pre-rheumatoid Stage or Something Else?

Authors:  Raimon Sanmartí; Beatriz Frade-Sosa; Rosa Morlà; Raul Castellanos-Moreira; Sonia Cabrera-Villalba; Julio Ramirez; Georgina Salvador; Isabel Haro; Juan D Cañete
Journal:  Front Med (Lausanne)       Date:  2021-03-25

Review 4.  Enthesitis in Psoriatic Arthritis, the Sonographic Perspective.

Authors:  Gianluca Smerilli; Andrea Di Matteo; Edoardo Cipolletta; Walter Grassi; Emilio Filippucci
Journal:  Curr Rheumatol Rep       Date:  2021-08-24       Impact factor: 4.592

Review 5.  The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on "At-Risk" Individuals.

Authors:  Laurence Duquenne; Rahaymin Chowdhury; Kulveer Mankia; Paul Emery
Journal:  Front Med (Lausanne)       Date:  2020-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.